. Despite rapid development of a range of COVID-19 vaccines using innovative technologies, access to these vaccines has been a … challenge, with manufacturing mostly concentrated in the US and Europe for high-value mRNA vaccines, and China and India for …. ASEAN countries, which overall have made limited investments in research and development of vaccines and biologicals, were …